Brief: FDA Authorizes Marketing Of Device To Improve Gait In Multiple Sclerosis Patients
26/03/2021 18:14
March 26 (Reuters) - FDA:
* FDA AUTHORIZES MARKETING OF DEVICE TO IMPROVE GAIT IN
MULTIPLE
SCLEROSIS PATIENTS
* FDA SAYS GRANTED MARKETING AUTHORIZATION OF THE PORTABLE
NEUROMODULATION STIMULATOR TO HELIUS MEDICAL, INC
Source text: (https://bit.ly/3u25kp9)
Further company coverage: HSDT.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Solana Co
See all newsBrief: Solana Co Pursuant To Prospectus Supplement, May Offer Shares Of Common Stock Of Up To $250 Million From Time To Time
Brief: Solana: On May 12, Dane C. Andreeff Resigns As CEO, President And Board Member
Solana Co Q1 revenue surges on staking rewards
Brief: Solana Company (Nasdaq Hsdt) Appoints Madelene Gani As Chief Operating Officer And Deputy CFO To Lead Next Phase Of Growth
Solana Co Q4 revenue surges on staking rewards, swings to profit